For decades, pancreatic cancer has defied targeted therapies by rapidly evolving escape mechanisms. In a new study, Spanish researchers report that a carefully designed three-drug strategy shut down those escape routes entirely in laboratory models, producing complete and durable tumor regression.

Discover how biotechnology is transforming cancer treatment, bringing us closer to a future of precision, hope, and potential cures.